Brain Advance Access originally published online on April 8, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 126, No. 6, 1382-1391,
June 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg126
Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system
1 Cambridge Centre for Brain Repair and Department of Clinical Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, 2 Animal Health Trust, Lanwades Park, Kentford, Newmarket, UK
Correspondence to: Dr R. J. M. Franklin, Department of Clinical Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, UK E-mail: rjf1000{at}cam.ac.uk
It has been hypothesized that the progressive failure of remyelination in chronic multiple sclerosis is, in part, the consequence of repeated episodes of demyelination at the same site, eventually depleting oligodendrocyte progenitor cells (OPCs) and exhausting the remyelinating capacity. We investigated the effect of previous focal, ethidium bromide-induced demyelination of brain stem white matter (with intervening recovery) on the efficiency of the remyelination process during second and third subsequent episodes of demyelination, and the OPC response during a second episode of demyelination. Previous focal demyelinating lesions followed by recovery did not result in any retardation of the remyelination process, nor did they alter the proportion of Schwann cell versus oligodendrocyte remyelination. The OPC response during remyelination was quantified by in situ hybridization using a probe to platelet-derived growth factor-
receptor (PDGFR), an OPC-expressed mRNA. Following recovery from focal, toxin-induced CNS demyelination, the OPC density returned to levels equivalent to those in normal white matter. Further more, there was no depletion of OPCs following repeated episodes of focal, toxin-induced CNS demyelination at the same site. These results indicate that repeated CNS demyelination, which has the opportunity to repair in the intervening period, is not characterized by impaired remyelination or depletion of OPCs.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Kuhlmann, V. Miron, Q. Cuo, C. Wegner, J. Antel, and W. Bruck Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis Brain, July 1, 2008; 131(7): 1749 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Williams, G. Piaton, M.-S. Aigrot, A. Belhadi, M. Theaudin, F. Petermann, J.-L. Thomas, B. Zalc, and C. Lubetzki Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain, October 1, 2007; 130(10): 2554 - 2565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nishiyama Polydendrocytes: NG2 Cells with Many Roles in Development and Repair of the CNS Neuroscientist, February 1, 2007; 13(1): 62 - 76. [Abstract] [PDF]
|
|
|
|
 |
|
 B. H. Dobkin Behavioral, Temporal, and Spatial Targets for Cellular Transplants as Adjuncts to Rehabilitation for Stroke Stroke, February 1, 2007; 38(2): 832 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Stidworthy, S. Genoud, W.-W. Li, D. P. Leone, N. Mantei, U. Suter, and R. J. M. Franklin Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination Brain, September 1, 2004; 127(9): 1928 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ruffini, T. E. Kennedy, and J. P. Antel Inflammation and Remyelination in the Central Nervous System: A Tale of Two Systems Am. J. Pathol., May 1, 2004; 164(5): 1519 - 1522. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Mason, A. Toews, J. D. Hostettler, P. Morell, K. Suzuki, J. E. Goldman, and G. K. Matsushima Oligodendrocytes and Progenitors Become Progressively Depleted within Chronically Demyelinated Lesions Am. J. Pathol., May 1, 2004; 164(5): 1673 - 1682. [Abstract] [Full Text] [PDF]
|
|